文献速递湿疹皮炎与荨麻疹

婴幼儿皮肤病生活质量量表(InToDermQoL)的验证

Validation of the dermatology-specific proxy instrument the Infants and Toddlers Dermatology Quality of Life.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-03-19

本研究在国际现场试验中验证了针对0-4岁皮肤病患儿的皮肤病特异性代理健康相关生活质量量表InToDermQoL。473名患儿的家长填写了相应语言版本,结果显示三个年龄版本(10、12、15个条目)均具有高内部一致性(Cronbach's α 0.90-0.93)、良好的重测信度(相关系数>0.9),与Infants Dermatitis Quality of Life Index显著相关(相关系数0.68-0.79),并能区分不同诊断和疾病严重程度。

要点

  • InToDermQoL三个年龄版本(10、12、15条目)内部一致性高(Cronbach's α 0.90-0.93)。
  • 重测信度良好,相关系数>0.9。
  • 与Infants Dermatitis Quality of Life Index显著相关(相关系数0.68-0.79)。

核心结论

  • 现场试验证实InToDermQoL具有内部一致性、重测信度、聚合效度和区分效度。

研究设计与样本

  • 国际现场试验,纳入473名皮肤病患儿的家长填写国家语言版本的InToDermQoL问卷。

主要发现

  • 三个年龄版本(10、12、15条目)的Cronbach's α为0.90-0.93。
  • 重测信度相关系数>0.9。
  • 与Infants Dermatitis Quality of Life Index的相关系数为0.68-0.79。
  • <3岁版本与Scoring of Atopic Dermatitis的相关系数分别为0.66(10条目)和0.86(12条目)。
  • 问卷能区分不同诊断和疾病严重程度。

临床怎么用

  • InToDermQoL可用于评估0-4岁皮肤病患儿的皮肤病特异性健康相关生活质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The first dermatology-specific proxy health-related quality of life (HRQoL) instrument for children 0-4 years old with skin diseases, the Infants and Toddlers Dermatology Quality of Life (InToDermQoL), was recently developed. In order to avoid the problem of cross-cultural inequivalence focus groups work and pilot tests were organized simultaneously in all national centres of the project. The InToDermQoL showed good comprehensibility, clarity and acceptance. OBJECTIVE: To validate the InToDermQoL questionnaire during international field tests. METHODS: Internal consistency, test-retest reliability, convergent and discriminant validity of the InToDermQoL questionnaire were checked during international field tests. RESULTS: Parents of 473 children with skin diseases filled in the national language versions of the InToDermQoL questionnaire. All three age-specific versions of the InToDermQoL questionnaire with 10, 12 and 15 items, respectively, showed high internal consistency (Cronbach's α 0.90-0.93), good test-retest reliability (correlation coefficients > 0.9), significant correlations with the most widely used atopic dermatitis-specific proxy instrument, the Infants Dermatitis Quality of Life Index (correlation coefficients 0.68-0.79). The InToDermQoL versions for children <3 years old well correlated with the atopic dermatis severity measure Scoring of Atopic Dermatitis (correlation coefficients 0.66 and 0.86 for 10 and 12 items versions, respectively). The InToDermQoL questionnaire discriminated well among different diagnoses and disease severity levels. CONCLUSION: Our field tests confirmed internal consistency, test-retest reliability, convergent and discriminant validity of the InToDermQoL questionnaire. Development and validation of the InToDermQoL questionnaire make it possible to assess dermatology-specific aspects of HRQoL in youngest children with skin diseases. There are many reasons to assess HRQoL in dermatologic clinical practice, and we hope that our new instrument will be used internationally in paediatric dermatology for research and practical needs.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Chernyshov PV, Sampogna F, Pustišek N, et al. Validation of the dermatology-specific proxy instrument the Infants and Toddlers Dermatology Quality of Life. J Eur Acad Dermatol Venereol. 2019. PMID: 30767284. doi:10.1111/jdv.15496

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。